Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page
- Check6 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4. This signals a minor update to the study document metadata on the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3 on the page, indicating a new version of the page template and related metadata. This change does not alter the study content or user-facing information.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.2. This appears to be a minor site update with no visible changes to the study details.SummaryDifference0.1%

- Check63 days agoChange DetectedThe revision indicator was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.4.3 was implemented, replacing the previous v3.4.2.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded a new site revision label Revision: v3.4.2, and removed the government funding status notice and the older Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.